Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

775
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
775
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

13.5K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.5K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.7K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

515
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
515
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

563
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
563

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnosis Frequency and Associated Factors of Nonalcoholic Fatty Liver Disease Among United States Hospitalized Adults in Urban vs Rural Populations From 2007 to 2019: An Emerging Public Health Crisis.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2025
Same author

Oral hyperpigmentation with weakness and salt-craving.

Cleveland Clinic journal of medicine·2022
Same author

Academic collaborations with industry: lessons for the future.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2020
Same author

Diagnosis of Diabetes Mellitus in Older Adults.

Clinics in geriatric medicine·2020
Same author

Artificial Intelligence and Digital Tools: Future of Diabetes Care.

Clinics in geriatric medicine·2020
Same author

Preface.

Clinics in geriatric medicine·2020

Related Experiment Video

Updated: Dec 17, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.2K

Improving Adherence in Type 2 Diabetes.

Khine Swe1, S Sethu K Reddy2

  • 1St. Mary's Ascension, CMU College of Medicine, Saginaw, MI, USA; Department of Internal Medicine, CMED 2419, Central Michigan University, Mt. Pleasant, MI 48859, USA.

Clinics in Geriatric Medicine
|June 27, 2020
PubMed
Summary
This summary is machine-generated.

Millions of adults have diabetes mellitus (DM), a condition often worsened by medication nonadherence, especially in older adults. Research aims to improve adherence for better diabetes management and fewer complications.

Keywords:
Medication persistencePrimary nonadherenceSecondary nonadherenceShared decision making

More Related Videos

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.8K
Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

12.9K

Related Experiment Videos

Last Updated: Dec 17, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.2K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.8K
Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

12.9K

Area of Science:

  • Endocrinology
  • Public Health
  • Geriatrics

Background:

  • Diabetes mellitus (DM) affects over half a billion adults globally, incurring substantial healthcare costs.
  • Nonadherence and nonpersistence to type 2 DM medications are significant barriers to effective disease management.
  • Older adults exhibit a particularly high prevalence of medication nonadherence.

Purpose of the Study:

  • To review research on the prevalence and predictors of medication adherence in type 2 DM.
  • To examine methodologies used in adherence research.
  • To discuss the development of adherence measurement tools.

Main Methods:

  • Literature review focusing on prevalence, predictors, and measurement of DM medication adherence.
  • Analysis of research methodologies in the field.
  • Synthesis of findings related to adherence barriers and facilitators.

Main Results:

  • Nonadherence is a widespread issue in type 2 DM, particularly impacting older populations.
  • Existing research has explored various facets of adherence, including its prevalence and contributing factors.
  • Development of standardized measures is crucial for consistent and reliable adherence assessment.

Conclusions:

  • Addressing medication nonadherence is critical for improving health outcomes in adults with DM.
  • Further research and improved adherence strategies are needed to reduce diabetes-related complications.
  • Enhanced disease monitoring and patient support can lead to better medication adherence.